Recruiting Obesity Studies in Marrero
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participan...
GV101 in Healthy Obese Participants
The purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change i...
About Obesity Clinical Trials in Marrero
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Marrero, LA. These studies are seeking a combined 292 participants. Research is being sponsored by NodThera Limited, Graviton Bioscience Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Marrero — FAQ
Are there obesity clinical trials in Marrero?
Yes, there are 2 obesity clinical trials currently recruiting in Marrero, LA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Marrero?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Marrero research site will contact you about next steps.
Are clinical trials in Marrero free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Marrero studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Marrero are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov